4SC

active

Planegg-Martinsried, Germany

Founded 1997

About

Autoimmune & Cancer Small Molecules

Areas of Focus

Categories

Small Molecule Pharmaceutical

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

44

By Phase

PHASE1/PHASE2: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2019

2020

2021

2022

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT04133948Collaborator

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

PHASE1/PHASE2Completed

44 participants

Started: Jan 7, 2020 · Completed: Nov 26, 2024

Funding History (2)

D/A

Apr 26, 2016

D

Nov 6, 2014

Locations (1)

Headquarters

Planegg-Martinsried, Germany

Map

Loading map...